C-CAMP launches AMR Quest 2020

26 February 2020 | News

A one of its kind programs focused on attracting, identifying, rewarding and fostering innovative ideas to fight superbugs and superbug-related infections

image credit- shuttershock.com

image credit- shuttershock.com

Antimicrobial Resistance (AMR), two words to have become a nightmare for clinicians, pharmaceutical companies, public health professionals and policymakers around the globe. As the world hurtles towards a future where the most potent antibiotics in a clinician’s arsenal are rendered useless, we as a society need better regulations, better policies and better innovations.

Innovations that address the superbug threat in a way that’s never been done before, innovations that are novel, holistic and conserved!

As research and innovation efforts in the AMR space race to keep up with these fast-evolving – deadly bugs, there is a need to identify, nurture and amplify game changing ideas in the sector with potential for instant impact on the problem.

Bengaluru based C-CAMP, the Centre for Cellular and Molecular Platforms, one of India’s premier bio innovation hubs has recognized the dire need for cutting-edge innovations in AMR to come to mainstream and the handholding support such ideas require to make the commercial ‘cut’. 

C-CAMP has announced a C-CAMP AMR Quest, a one of its kind programs focused on attracting, identifying, rewarding and fostering innovative ideas to fight superbugs and superbug-related infections. The initiative aims to present opportunities for funding and guide these ideas through their commercialization trajectory.

“To truly tackle the AMR havoc, deep tech innovations and awareness are critical!! This C-CAMP AMR Quest will foster innovators in the domain of Antimicrobial Resistance and promote them in the global community,” said Dr. Taslimarif Syed, CEO & Director, C-CAMP.

Every such idea that will make the transition from bench to bedside is a win. Because Antimicrobial Resistance affects us all!

The Winners of the Quest that will end with a Grand Finale in April will be

Accepted into a 3-month C-CAMP Accelerator program and will be evaluated for funding by CARB-X and

Participation in any one of the following International Conferences/Programs, with all costs covered:                                                                                               

  • iCARE, International Course on Antibiotics and Resistance, held at Institut Pasteur, Les Pensières, Annecy, France
  • EU AMR Innovations Mission, UK held in England from 26 October to 30 October
  • Emerging Antimicrobials and Diagnostics in AMR 2020 held in Amsterdam, 18 Nov to 19 Nov

World Health Summit, Berlin, Germany from October 25 to 27

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account